Glucose transporter 10 modulates adipogenesis via an ascorbic acid-mediated pathway to protect mice against diet-induced metabolic dysregulation

PLoS Genet. 2020 May 26;16(5):e1008823. doi: 10.1371/journal.pgen.1008823. eCollection 2020 May.

Abstract

The development of type 2 diabetes mellitus (T2DM) depends on interactions between genetic and environmental factors, and a better understanding of gene-diet interactions in T2DM will be useful for disease prediction and prevention. Ascorbic acid has been proposed to reduce the risk of T2DM. However, the links between ascorbic acid and metabolic consequences are not fully understood. Here, we report that glucose transporter 10 (GLUT10) maintains intracellular levels of ascorbic acid to promote adipogenesis, white adipose tissue (WAT) development and protect mice from high-fat diet (HFD)-induced metabolic dysregulation. We found genetic polymorphisms in SLC2A10 locus are suggestively associated with a T2DM intermediate phenotype in non-diabetic Han Taiwanese. Additionally, mice carrying an orthologous human Glut10G128E variant (Glut10G128E mice) with compromised GLUT10 function have reduced adipogenesis, reduced WAT development and increased susceptibility to HFD-induced metabolic dysregulation. We further demonstrate that GLUT10 is highly expressed in preadipocytes, where it regulates intracellular ascorbic acid levels and adipogenesis. In this context, GLUT10 increases ascorbic acid-dependent DNA demethylation and the expression of key adipogenic genes, Cebpa and Pparg. Together, our data show GLUT10 regulates adipogenesis via ascorbic acid-dependent DNA demethylation to benefit proper WAT development and protect mice against HFD-induced metabolic dysregulation. Our findings suggest that SLC2A10 may be an important HFD-associated susceptibility locus for T2DM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipogenesis
  • Adipose Tissue, White / metabolism*
  • Adult
  • Aged
  • Animals
  • Ascorbic Acid / metabolism*
  • CCAAT-Enhancer-Binding Proteins / genetics
  • DNA Methylation* / drug effects
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetes Mellitus, Type 2 / metabolism
  • Diet, High-Fat / adverse effects*
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation / drug effects
  • Glucose Transport Proteins, Facilitative / genetics*
  • Glucose Transport Proteins, Facilitative / metabolism
  • Glycated Hemoglobin / metabolism
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Middle Aged
  • Mutation
  • PPAR gamma / genetics

Substances

  • CCAAT-Enhancer-Binding Proteins
  • CEBPA protein, mouse
  • Glucose Transport Proteins, Facilitative
  • Glycated Hemoglobin A
  • PPAR gamma
  • Pparg protein, mouse
  • SLC2A10 protein, human
  • Slc2A10 protein, mouse
  • hemoglobin A1c protein, human
  • Ascorbic Acid

Grants and funding

This study was supported by grants from Academia Sinica, Taiwan (AS 105-TP-B04) and the Ministry of Science and Technology (MOST), Taiwan (MOST 107-2320-B-001-024 and MOST 108-2320-B-001-022) to YCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.